The neuroprotective effect of lamotrigine against glutamate excitotoxicity in SH-SY5Y human neuroblastoma cells
Objective: Glutamate-induced excitotoxicity has a role in the pathophysiology of neurodegenerative disorders. Lamotrigine, an antiepileptic drug, also used to treat bipolar disorders, may be protective against excitotoxic insult. The aim of the study was to investigate the neuroprotective effect of lamotrigine against the glutamate excitotoxicity in SH-SY5Y cell line. Materials and Methods: SH-SY5Y human neuroblastoma cells were pre-treated with lamotrigine (50-100-150 μM) prior to exposure to 15 mM glutamate. The 3-(4,5-dimethythiazol – 2-yl)-2,5 – diphenyl tetrazolium bromide (MTT) assay was performed to determine cell viability. The anti-oxidant effect of lamotrigine and the role of inflammatory parameters were determined by measuring superoxide dismutase (SOD), hydrogen peroxide (H2O2), IL-1β, IL-6 and TNF-α. Results: Intracellular calcium levels and lactate dehydrogenase (LDH) activity increased in glutamate exposed cells. Pre-treatment of cells with MK-801 showed no protective features against glutamate excitotoxicity. Treatment with 100 μM lamotrigine was effective in increasing the viability of glutamate exposed cells and in reducing H2O2 increase in these cells. The SOD activity increased by lamotrigine treated cells exposed to glutamate. IL-1β, IL-6 and TNF-α levels increased after induction with glutamate and attenuated by lamotrigine. Conclusion: Overall, our results confirmed the critical role of inflammation and oxidative stress in glutamate-induced excitotoxicity and lamotrigine may exert a protective effect. Keywords: Lamotrigine, Glutamate excitotoxicity,
___
- Bhagwagar Z, Goodwin GM. Lamotrigine in the treatment of
bipolar disorder. Expert Opin Pharmacother 2005;6:1401-8.
doi:10.1517/14656566.6.8.1401
- Bowden CL. Acute and maintenance treatment with mood
stabilizers. Int J Neuropsychopharmacol 2003;6:269-75.
doi:10.1017/S146.114.5703003535
- Cook AM, Bensalem-Owen MK. Mechanisms of action of
antiepileptic drugs. Therapy 2011;8:307-13
- Mantegazza M, Curia G, Biagini G, Ragsdale DS, Avoli M.
Voltage-gated sodium channels as therapeutic targets in
epilepsy and other neurological disorders. Lancet Neurol
2010;9:413-24. doi: 10.1016/S1474-4422(10)70059-4
- Rothman SM, Olney JW. Glutamate and the pathophysiology
of hypoxic—ischemic brain damage. Ann Neurol 1986;19:105-
11.
- Bleich S, Romer K, Wiltfang J, Kornhuber J. Glutamate and
the glutamate receptor system: a target for drug action. Int J
Geriatr Psychiatry 2003;18(Suppl 1):S33-40.
- Halonen T, Nissinen J, Pitkänen A. Effect of lamotrigine
treatment on status epilepticus-induced neuronal damage and
memory impairment in rat. Epilepsy Res 2001;46: 205-23. doi:
10.1016/s0920-1211(01)00278-9.
- Calabresi P, Picconi B, Saulle E, Centonze D, Hainsworth AH,
Bernardi G. Is pharmacological neuroprotection dependent
on reduced glutamate release? Stroke 2000;31:766-72. doi:
10.1161/01.str.31.3.766
- Papazisis G, Kallaras K, Kaiki-Astara A, et al. Neuroprotection
by lamotrigine in a rat model of neonatal hypoxic–ischaemic
encephalopathy. Int J Neuropsychopharmacol 2008;11:321-9.
doi: 10.1017/S146.114.5707008012.
- Belov Kirdajova D, Kriska J, Tureckova J, Anderova M.
Ischemia-triggered glutamate excitotoxicity from the
perspective of glial cells. Front Cell Neurosci 2020;14:51.
doi:10.3389/fncel.2020.00051.
- Chen WW, Zhang X, Huang WJ. Role of neuroinflammation
in neurodegenerative diseases (Review). Mol Med Rep
2016;13:3391-96. doi:10.3892/mmr.2016.4948
- Ward RJ, Dexter DT, Crichton RR. Ageing, neuroinflammation
and neurodegeneration. Front Biosci (Schol Ed) 2015;7:189-
204.
- Walker MC, Tong X, Perry H, Alavijeh MS, Patsalos PN.
Comparison of serum, cerebrospinal fluid and brain
extracellular fluid pharmacokinetics of lamotrigine. Br J
Pharmacol 2000;130:242–48. doi:10.1038/sj.bjp.0703337
- Leng Y, Fessler EB, Chuang DM. Neuroprotective effects of the
mood stabilizer lamotrigine against glutamate excitotoxicity:
Roles of chromatin remodelling and Bcl-2 induction. Int
J Neuropsychopharmacol 2013;16:607-20. doi:10.1017/
S146.114.5712000429.
- Johannessen SI, Battino D, Berry DJ, et al. Therapeutic drug
monitoring of the newer antiepileptic drugs. Ther Drug Monit
2003;25:347-63. doi:10.1097/00007.691.200306000-00016
- Naarala J, Nykvist P, Tuomala M, Savolainen K. Excitatory
amino acid-induced slow biphasic responses of free
intracellular calcium in human neuroblastoma cells. FEBS
Lett 1993;330:222-6. doi:10.1016/0014-5793(93)80278-3.
- Nair VD, Niznik HB, Mishra RK. Interaction of NMDA
and dopamine D2 receptors in human neuroblastoma
SH-SY5Ycells. J. Neurochem 1996;66:2390-93.
doi:10.1046/j.1471-4159.1996.660.62390.
- Sun ZW, Zhang L, Zhu SJ, Chen WC, Mei B. Excitotoxicity
effects of glutamate on human neuroblastoma SH-SY5Y cells
via oxidative damage. Neurosci Bull 2010;26:8-16. doi:10.1007/
s12264.010.0813-7
- Xie HR, Hu LS, Li GY. SH-SY5Y human neuroblastoma
cell line: in vitro cell model of dopaminergic neurons in
Parkinson’s disease. Chin Med J (Engl) 2010;123:1086-92.
- Hanada T. Ionotropic glutamate receptors in epilepsy: A review
focusing on AMPA and NMDA receptors. Biomolecules
2020;10(3):464:1-22. doi:10.3390/biom10030464
- Schubert D, Piasecki D. Oxidative glutamate toxicity can
be a component of the excitotoxicity cascade. J Neurosci
2001;21:7455-62. doi:10.1523/JNEUROSCI.21-19-07455.2001
- Gudiño-Cabrera G, Ureña-Guerrero ME, Rivera-Cervantes
MC, Feria-Velasco AI, Beas-Zárate C. Excitotoxicity triggered
by neonatal monosodium glutamate treatment and bloodbrain
barrier function. Arch Med Res 2014;45:653-9.
doi:10.1016/j.arcmed.2014.11.014
- Parpura V, Grubišić V, Verkhratsky A. Ca(2+) sources
for the exocytotic release of glutamate from astrocytes.
Biochim Biophys Acta 2011;1813:984-91. doi:10.1016/j.
bbamcr.2010.11.006
- Hamadi A, Giannone G, Takeda K, Rondé P. Glutamate
involvement in calcium-dependent migration of astrocytoma
cells. Cancer Cell Int 2014;14:42. doi:10.1186/1475-2867-14-
42
- Friedman LK. Calcium: a role for neuroprotection and
sustained adaptation. Mol Interv 2006;6:315-29. doi:10.1124/
mi.6.6.5
- Choi DW. Glutamate neurotoxicity in cortical cell culture
is calcium dependent. Neurosci Lett 1985;58:293-7.
doi:10.1016/0304-3940(85)90069-2
- Von Wegerer J, Hesslinger B, Berger M, Walden J. A calcium
antagonistic effect of the new antiepileptic drug lamotrigine.
Eur Neuropsychopharmacol 1997;7:77-81. doi:10.1016/s0924-
977x(96)00384-7
- Song JH, Kang KS, Choi YK. Protective effect of casuarinin
against glutamate-induced apoptosis in HT22 cells
through inhibition of oxidative stress-mediated MAPK
phosphorylation. Bioorg Med Chem Lett 2017;27:5109-13.
doi:10.1016/j.bmcl.2017.10.075
- Sies H. Hydrogen peroxide as a central redox signaling
molecule in physiological oxidative stress: Oxidative eustress.
Redox Biol 2017;11:613-19. doi:10.1016/j.redox.2016.12.035
- Ha JS, Lim HM, Park SS. Extracellular hydrogen peroxide
contributes to oxidative glutamate toxicity. Brain Res
2010;1359:291-97. doi:10.1016/j.brainres.2010.08.086
- Lobysheva NV, Selin AA, Vangeli IM, Byvshev IM, Yaguzhinsky
LS, Nartsissov YR. Glutamate induces H2O2 synthesis
in nonsynaptic brain mitochondria. Free Radic Biol Med
2013;65:428-35. doi:10.1016/j.freeradbiomed.2013.07.030
- Lee HJ, Spandidos DA, Tsatsakis A, Margina D, Izotov BN,
Yang SH. Neuroprotective effects of Scrophularia buergeriana
extract against glutamate-induced toxicity in SH-SY5Y cells.
Int J Mol Med 2019;43:2144-52. doi:10.3892/ijmm.2019.4139
- He L, He T, Farrar S, Ji L, Liu T, Ma X. Antioxidants maintain
cellular redox homeostasis by elimination of reactive
oxygen species. Cell Physiol Biochem 2017;44:532-53.
doi:10.1159/000485089
- Kasperczyk S, Birkner E, Kasperczyk A, Zalejska-Fiolka
J. Activity of superoxide dismutase and catalase in people
protractedly exposed to lead compounds. Ann Agric Environ
Med 2004;11:291-96.
- Kamal SM. Possible anti-oxidant effect of lamotrigine in
nucleus accumbens of mice exposed to picrotoxin. J Neurol
Disord 2013;1:108:1-5 doi: 10.4172/2329-6895.100.0108
- Eren I, Naziroğlu M, Demirdaş A. Protective effects of
lamotrigine, aripiprazole and escitalopram on depressioninduced
oxidative stress in rat brain. Neurochem Res.
2007;32:1188-95. doi:10.1007/s11064.007.9289-x
- Xu J, Wu W, Zhang H, Yang L. Berberine alleviates amyloid β25-
35-induced inflammatory response in human neuroblastoma
cells by inhibiting proinflammatory factors. Exp Ther Med
2018;16:4865-72. doi:10.3892/etm.2018.6749
- Li N, Song J, Kong L, et al. Neuroprotection of TSG against
mechanical trauma injury through an anti-inflammatory
mechanism in human neuroblastoma SH-SY5Y cells. Int J
Pharmacol 2016;12:789-800. doi:10.3923/ijp.2016.789.800
- Teeling JL, Perry VH. Systemic infection and inflammation in
acute CNS injury and chronic neurodegeneration: underlying
mechanisms. Neuroscience 2009;158:1062-73. doi:10.1016/j.
neuroscience.2008.07.031
- Rosales-Corral S, Reiter RJ, Tan DX, Ortiz GG, Lopez-
Armas G. Functional aspects of redox control during
neuroinflammation. Antioxid Redox Signal 2010;13:193-247.
doi:10.1089/ars.2009.2629
- Abu-Rish EY, Elhayek SY, Mohamed YS, Hamad I, Bustanji
Y. Evaluation of immunomodulatory effects of lamotrigine in
BALB/c mice. Acta Pharm 2017;67:543-55. doi:10.1515/acph-
2017-0035
- Abu-Rish EY, Dahabiyeh LA, Bustanji Y, Mohamed YS, Browning
MJ. Effect of lamotrigine on in vivo and in vitro cytokine
secretion in murine model of inflammation. J Neuroimmunol
2018;322:36-45. doi:10.1016/j.jneuroim.2018.06.008
- Himmerich H, Bartsch S, Hamer H, et al. Impact of mood
stabilizers and antiepileptic drugs on cytokine production
in-vitro. J Psychiatr Res 2013;47:1751-59. doi:10.1016/j.
jpsychires.2013.07.026
- Himmerich H, Bartsch S, Hamer H, et al. Modulation of
cytokine production by drugs with antiepileptic or mood
stabilizer properties in anti-CD3 – and anti-Cd40-stimulated
blood in vitro. Oxid Med Cell Longev 2014;2014:806162.
doi:10.1155/2014/806162